EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+1.57%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.61B
AUM Growth
+$36.4M
(+2.3%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
6.47%
Top 10 Holdings %
Top 10 Hldgs %
61.46%
Holding
387
New
81
Increased
131
Reduced
147
Closed
19
Top Buys
| 1 |
ASE Group
ASX
|
$25.3M |
| 2 |
Microsoft
MSFT
|
$12.9M |
| 3 |
NVIDIA
NVDA
|
$11.9M |
| 4 |
Apple
AAPL
|
$9.18M |
| 5 |
Amazon
AMZN
|
$7.47M |
Top Sells
| 1 |
Sea Limited
SE
|
$24.3M |
| 2 |
Advanced Micro Devices
AMD
|
$16.8M |
| 3 |
TSMC
TSM
|
$8M |
| 4 |
Weibo
WB
|
$2.43M |
| 5 |
Pinduoduo
PDD
|
$2.4M |
Sector Composition
| 1 | Consumer Discretionary | 40.2% |
| 2 | Technology | 29.79% |
| 3 | Communication Services | 9.9% |
| 4 | Healthcare | 5.71% |
| 5 | Real Estate | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
CDW
CDW
$21.8B
| $575K | 0.04% |
2,249
-13
| -0.6% | -$3.33K |
|
152
ICICI Bank
IBN
$114B
| $574K | 0.04% |
+21,719
| New | +$574K |
|
153
Moody's
MCO
$89.6B
| $560K | 0.03% |
+1,425
| New | +$560K |
|
154
Datadog
DDOG
$46B
| $549K | 0.03% |
4,440
-1,169
| -21% | -$144K |
|
155
Copart
CPRT
$48.3B
| $542K | 0.03% |
9,364
-130
| -1% | -$7.53K |
|
156
Marvell Technology
MRVL
$55.3B
| $513K | 0.03% |
7,231
-195
| -3% | -$13.8K |
|
|
ANSS
157
DELISTED
Ansys
ANSS
| $504K | 0.03% |
1,452
-37
| -2% | -$12.8K |
|
158
Exact Sciences
EXAS
$9.73B
| $498K | 0.03% |
7,218
-203
| -3% | -$14K |
|
159
Viking Therapeutics
VKTX
$2.98B
| $495K | 0.03% |
6,038
-16,157
| -73% | -$1.32M |
|
160
Motorola Solutions
MSI
$79.7B
| $488K | 0.03% |
1,376
-26
| -2% | -$9.23K |
|
161
Ross Stores
ROST
$50B
| $488K | 0.03% |
3,325
-69
| -2% | -$10.1K |
|
162
Crinetics Pharmaceuticals
CRNX
$3.23B
| $480K | 0.03% |
10,248
-2,821
| -22% | -$132K |
|
163
Workday
WDAY
$61.7B
| $477K | 0.03% |
1,748
-1,836
| -51% | -$501K |
|
164
Trex
TREX
$6.68B
| $475K | 0.03% |
+4,763
| New | +$475K |
|
165
Exelixis
EXEL
$10.1B
| $463K | 0.03% |
19,512
-2,320
| -11% | -$55.1K |
|
166
Cytokinetics
CYTK
$5.95B
| $462K | 0.03% |
6,591
-7,494
| -53% | -$525K |
|
167
Camtek
CAMT
$3.57B
| $462K | 0.03% |
5,516
-3,111
| -36% | -$261K |
|
168
Dyne Therapeutics
DYN
$1.88B
| $462K | 0.03% |
+16,275
| New | +$462K |
|
169
Old Dominion Freight Line
ODFL
$31.3B
| $457K | 0.03% |
2,084
-34
| -2% | -$7.46K |
|
170
BridgeBio Pharma
BBIO
$9.91B
| $455K | 0.03% |
14,711
-58
| -0.4% | -$1.79K |
|
171
Madrigal Pharmaceuticals
MDGL
$9.61B
| $453K | 0.03% |
1,698
-608
| -26% | -$162K |
|
172
Sarepta Therapeutics
SRPT
$1.93B
| $451K | 0.03% |
3,485
-2,034
| -37% | -$263K |
|
173
Canadian Pacific Kansas City
CP
$70.5B
| $450K | 0.03% |
+5,099
| New | +$450K |
|
174
Krystal Biotech
KRYS
$4.33B
| $449K | 0.03% |
2,522
-1,973
| -44% | -$351K |
|
175
Rhythm Pharmaceuticals
RYTM
$6.95B
| $448K | 0.03% |
10,333
+3,800
| +58% | +$165K |
|